Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

Published:2015 Issue:2 Volume:21 Page:125
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Yang Suh Yoon¹,Lee Hyun Woong¹,Lee Youn Jae²,Park Sung Jae²,Yoo Ki Young³,Kim Hyung Joon¹

Affiliation:

1. Department of Gastrohepatology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.

2. Department of Gastrohepatology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.

3. Korea Hemophilia Foundation Hospital, Seoul, Korea.

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://synapse.koreamed.org/pdf/10.3350/cmh.2015.21.2.125

Reference19 articles.

1. When to treat and the benefits of treating hepatitis C in patients with haemophilia

2. The natural history and antiviral treatment of hepatitis C in haemophilia

3. Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature

4. Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience

5. Efficacy of peg-interferon-α-2a plus ribavirin for patients aged 60 years and older with chronic hepatitis C in Korea

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia;Journal of Clinical Medicine;2022-03-07

2. Viral hepatitis in haemophilia: historical perspective and current management;British Journal of Haematology;2021-05-06

3. Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced;Gut and Liver;2017-09-15

4. KASL clinical practice guidelines: management of hepatitis C;Clinical and Molecular Hepatology;2016-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3